Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-25 @ 3:08 AM
Ignite Modification Date: 2025-12-26 @ 1:47 AM
NCT ID: NCT01579305
Description: None
Frequency Threshold: 5
Time Frame: None
Study: NCT01579305
Study Brief: Safety and Effectiveness of Juvéderm® Volbella With Lidocaine Versus Restylane-L® for Lip Volume Enhancement
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Subjects Treated With VOLBELLA® None None None 1 139 27 139 View
Subjects Treated With Restylane-L® None None None 1 141 26 141 View
Serious Events(If Any):

Serious Events

Term Type Organ System Vocab View
Tendon rupture SYSTEMATIC_ASSESSMENT Injury, poisoning and procedural complications MedDRA 16.1 View
Breast cancer SYSTEMATIC_ASSESSMENT Neoplasms benign, malignant and unspecified (incl cysts and polyps) MedDRA 16.1 View
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
Injection site mass SYSTEMATIC_ASSESSMENT General disorders MedDRA 16.1 View
Injection site pain SYSTEMATIC_ASSESSMENT General disorders MedDRA 16.1 View
Oral herpes SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA 16.1 View